Limits...
The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B - Vaccines (Basel) (2015)

Bottom Line: China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response.This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection.A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

View Article: PubMed Central - PubMed

Affiliation: International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.

ABSTRACT
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

No MeSH data available.


Related in: MedlinePlus

Spatial distribution of reported people living with HIV/AIDS by 2010. Note: Provinces with labels participated this program. All 13 provinces had reported 87.8% of diagnosed people living with HIV/AIDS by the end of 2010). Adapted from [4].
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494240&req=5

vaccines-03-00001-f002: Spatial distribution of reported people living with HIV/AIDS by 2010. Note: Provinces with labels participated this program. All 13 provinces had reported 87.8% of diagnosed people living with HIV/AIDS by the end of 2010). Adapted from [4].

Mentions: Data collection for the project was facilitated by the engagement of epidemiological staff at NCAIDS from 13 provinces (Box 1 , Figure 2) that met the following criteria:


The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B - Vaccines (Basel) (2015)

Spatial distribution of reported people living with HIV/AIDS by 2010. Note: Provinces with labels participated this program. All 13 provinces had reported 87.8% of diagnosed people living with HIV/AIDS by the end of 2010). Adapted from [4].
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494240&req=5

vaccines-03-00001-f002: Spatial distribution of reported people living with HIV/AIDS by 2010. Note: Provinces with labels participated this program. All 13 provinces had reported 87.8% of diagnosed people living with HIV/AIDS by the end of 2010). Adapted from [4].
Mentions: Data collection for the project was facilitated by the engagement of epidemiological staff at NCAIDS from 13 provinces (Box 1 , Figure 2) that met the following criteria:

Bottom Line: China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response.This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection.A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

View Article: PubMed Central - PubMed

Affiliation: International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.

ABSTRACT
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

No MeSH data available.


Related in: MedlinePlus